United Kingdom

People: Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

18 Jun 2019
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Cheng, Cheung Ling 

Ms. Cheng Cheung Ling serves as Executive Vice Chairlady of the Board of Sino Biopharmaceutical Ltd. Ms. Cheng graduated from the Guanghua School of Management of Peking University and obtained a Master Degree in Business Administration. She is a clinician. Ms. Cheng has extensive experience in and a discerning vision for management and investment in the pharmaceutical industry. She spares no effort in promoting innovation and R&D capabilities in the industry. She is the chairman of Beijing Tide. Being at the helm of Beijing Tide, Ms. Cheng advocates for innovations in R&D, production, sales, and management, and has led Beijing Tide to step up its efforts in developing international collaboration, with an aim to promote rapid development of cutting-edge technologies for medical products in China, and to give top priority to quality control, considering product quality as the lifeblood of the company. Under her leadership, Beijing Tide has achieved tremendous growth, riding on internationalization and innovation. Beijing Tide has become a leading company for the development of targeted drugs in China, being ranked one of the “Top 50 Pharmaceutical Companies in China” (based on data of Ministry of Industry and Information Technology for 2016) and the 4th place of “Pharmaceutical Industry Enterprises with Most Investment Value in the PRC” (awarded by National Pharmaceutical Industry Information Annual Conference 2017).

Basic Compensation

Total Annual Compensation, HKD 11,100,000
Restricted Stock Award, HKD --
Long-Term Incentive Plans, HKD --
All Other, HKD 16,000
Fiscal Year Total, HKD 11,116,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Y Y Tse


Ping Tse


Cheung Ling Cheng


Minggang Wang


Chun Ling Li


Hsin Tse

As Of  31 Dec 2017